Evogene Ltd.
EVGN
$0.97
-$0.0255-2.56%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 5.64M | 5.72M | 5.72M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 5.64M | 5.72M | 5.72M |
| Cost of Revenue | -- | -- | 1.69M | 1.66M | 1.66M |
| Gross Profit | -- | -- | 3.95M | 4.06M | 4.06M |
| SG&A Expenses | -- | -- | 9.68M | 10.24M | 10.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -3.50M | -3.50M |
| Total Operating Expenses | -- | -- | 32.15M | 28.38M | 28.38M |
| Operating Income | -- | -- | -26.51M | -22.66M | -22.66M |
| Income Before Tax | -- | -- | -25.99M | -22.42M | -22.42M |
| Income Tax Expenses | -- | -- | -33.00K | 16.00K | 16.00K |
| Earnings from Continuing Operations | -- | -- | -25.95 | -22.44 | -22.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 2.08M | 2.16M | 2.16M |
| Net Income | -- | -- | -23.88M | -20.28M | -20.28M |
| EBIT | -- | -- | -26.51M | -22.66M | -22.66M |
| EBITDA | -- | -- | -23.90M | -20.07M | -20.07M |
| EPS Basic | -- | -- | -5.32 | -4.74 | -4.74 |
| Normalized Basic EPS | -- | -- | -2.24 | -1.75 | -1.75 |
| EPS Diluted | -- | -- | -5.32 | -4.74 | -4.74 |
| Normalized Diluted EPS | -- | -- | -2.24 | -1.75 | -1.75 |
| Average Basic Shares Outstanding | -- | -- | 18.26M | 17.33M | 17.33M |
| Average Diluted Shares Outstanding | -- | -- | 18.26M | 17.33M | 17.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |